After a long bike race, most people’s blood tests show troponin levels high enough to be diagnosed as a heart attack—even though their hearts are actually fine.
Scientific Claim
Current biomarker criteria for diagnosing acute myocardial infarction are met in 76–87% of individuals using hs-cTnI and 95–96% using hs-cTnT within 3 hours after endurance cycling, despite the absence of acute cardiac injury.
Original Statement
“The biomarker criteria for MI were met in 76-87% for hs-cTnI, and 96-95% for hs-cTnT (p value <0.05), within the first 3 h post-race.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study observes that thresholds were exceeded, but does not compare to true MI cases or prove misdiagnosis. 'Met' is factual, but the implication of diagnostic inaccuracy requires causal evidence not present.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aThe pooled rate of false-positive MI diagnoses in athletes post-exercise across assays and populations.
The pooled rate of false-positive MI diagnoses in athletes post-exercise across assays and populations.
What This Would Prove
The pooled rate of false-positive MI diagnoses in athletes post-exercise across assays and populations.
Ideal Study Design
A meta-analysis of 15+ studies comparing hs-cTnI and hs-cTnT thresholds in 2,000+ athletes post-endurance events versus 2,000+ patients with confirmed acute MI, using identical assay protocols and diagnostic criteria, with adjudicated outcomes.
Limitation: Cannot determine clinical consequences of misclassification.
Randomized Controlled TrialLevel 1bWhether modifying troponin thresholds or adding clinical variables improves diagnostic accuracy in athletes.
Whether modifying troponin thresholds or adding clinical variables improves diagnostic accuracy in athletes.
What This Would Prove
Whether modifying troponin thresholds or adding clinical variables improves diagnostic accuracy in athletes.
Ideal Study Design
A double-blind RCT of 500 athletes with post-exercise troponin elevation, randomized to standard MI criteria vs. modified criteria (e.g., higher threshold + ECG + imaging), with blinded adjudication of true MI status by independent cardiologists.
Limitation: Ethical constraints prevent inducing true MI in controls.
Prospective Cohort StudyLevel 2bThe long-term clinical outcomes of athletes who exceed MI thresholds post-exercise without confirmed cardiac injury.
The long-term clinical outcomes of athletes who exceed MI thresholds post-exercise without confirmed cardiac injury.
What This Would Prove
The long-term clinical outcomes of athletes who exceed MI thresholds post-exercise without confirmed cardiac injury.
Ideal Study Design
A prospective cohort of 1,000 athletes with post-exercise troponin >99th percentile, followed for 5 years with annual cardiac imaging and event tracking to determine if elevated troponin predicts future cardiac events.
Limitation: Cannot prove causality between troponin elevation and future disease.
Evidence from Studies
Supporting (1)
After a long bike race, many people’s blood tests show troponin levels high enough to be mistaken for a heart attack — even though their hearts are fine. This study proves that the current medical rules for diagnosing heart attacks can wrongly flag healthy athletes.